BP003891: Human Neuropilin-1 Protein with the C-His Tag

Source: The recombinant Human Neuropilin-1 Protein, (amino acids Phe22-Lys644) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF165 protein with the C-His tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human Neuropilin-1 protein with the C-His tag with the EC50 of 0.57 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP003899: Mouse VEGF R2/KDR Protein with the C-His Tag

Source: The recombinant Mouse VEGF R2/KDR Protein, (amino acids Ala20-Glu762) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF165 protein with the C-His tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Mouse VEGFR2 protein with the C-His tag with the EC50 of 1.15 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP005736: Biotinylated Human VEGF R1/FLT-1 Protein with the C-His-Avi Tag

Source: The recombinant Biotinylated Human VEGF R1/FLT-1 Protein, (amino acids Ser27-Asn756) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF165 protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Human VEGFR1 protein with the C-His tag with the EC50 of 46.4 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP003701: Biotinylated Human VEGF R2/KDR Protein with the C-mFc Tag

Source: The recombinant Biotinylated Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF165 protein with the C-mFc tag at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Human VEGF R2 protein with the C-mFc tag with the EC50 of 98.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP004956: Biotinylated Human VEGF R2/KDR Protein with the C-His-Avi Tag

Source: The recombinant Biotinylated Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human VEGF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-VEGF R2 Antibody protein with the C-hFc tag with the EC50 of 8.2 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP005766: Human VEGF R2/KDR Protein with the C-mFc Tag

Source: The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF165 protein with the C-mFc tag 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human VEGF R2 protein with the C-mFc tag with the EC50 of 42.3 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

BP005397: Human VEGF R2/KDR Protein with the C-His-Avi Tag

Source: The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well). Dose response curve for the recombinant Anti-VEGFR2 Antibody protein with the C-hFc tag with the EC50 of 5.5 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.

C069P: Brolucizumab Biosimilar, VEGF-A Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade brolucizumab biosimilar specifically binds to the human vascular endothelial growth factor A (VEGF-A).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by brolucizumab.

BP000027-GD1: Recombinant Human VEGF165 (aa 27-191) Protein

Source: HEK 293 cell-derived.
The VEGF activity is measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 1-5 ng/ml.
Endotoxin: < 1.0 EU per ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions.

BP000027-CYT-574: Recombinant Mouse VEGF (121 a.a) Protein

Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.

PA006153-PA1771: Neuropilin-2 Polyclonal Antibody

Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Rat, Mouse;
Isotype: Rabbit IgG.

BP000027-CYT-260: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, CHO

Source: Chinese Hamster Ovarian Cell-derived.
Determined by its ability to stimulate 3H-Thymidine incorporation in human ublical vein endothelial cells, the ED50 for this effect was found to be 2-6 ng/ml corresponding to a Specific Activity of 166,667-500,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.